Advertisement

Topics

nThrive Selects Board of Directors

05:10 EDT 29 Jun 2017 | PR Newswire

ALPHARETTA, Ga., June 29, 2017 /PRNewswire/ -- nThrive is pleased to announce the formation of its Board of Directors as well as the appointment of five distinguished members to this group. Though not required by company structure, with the strong momentum the company is experiencing in the marketplace, nThrive leadership chose to establish a Board of Directors. After careful review, the company has selected accomplished individuals representing an array of experiences that lend themselves to supporting the continued growth of nThrive.

This new Board consists of Joel Hackney, Chief Executive Officer at nThrive, Jeremy Gelber, M.D., Partner at Pamplona Capital Management, Mark Pacala, Operating Partner at Pamplona Capital Management, Nido Qubein, D.H.L, President at High Point University, and Peter N. Foss, General Manager GE/NFL Head Health Program. "The tremendous leadership that has been attracted to this board will provide objective input as to the strategic direction of the company, as well as to advise and support governance of other corporate matters," Bringing these minds together is another important step nThrive is taking towards delivering on its mission to empower health care for every one in every community," observes Hackney.

Get to know the Board of DirectorsJoel Hackney is chief executive officer for nThrive, a leading revenue cycle solutions company that enables health care organizations to thrive by transforming their financial and operational performance. A seasoned executive with 25 years leading both private and public companies in the U.S. and abroad, Hackney is a values based leader with deep expertise in driving market leadership and profitable growth. As leader, Hackney sees his role, and the role of nThrive, to ensure that all people have the opportunity to live healthy, happy lives.

From Pamplona Capital Management, nThrive's private equity owner with more than $10 billion under management, Dr. Gelber focuses on investments in the health care sector. Gelber serves on the board of Brighton Health, Intralign, Spreemo, Alvogen and nThrive. He received his M.D. from Jefferson Medical College and his B.S. from Dartmouth College.

Mark Pacala offers more than 30 years of general management and private equity experience in health care and consumer services companies. In 1994, Mr. Pacala entered the health care industry, where he remains to this day. Mr. Pacala joined Pamplona Capital in 2015 as an Operating Partner focusing on health care investments. Since 1994, Mr. Pacala has served as CEO of several health care services companies including the Forum Group, American WholeHealth and AccentCare, as well as served on numerous company boards.

Dr. Nido Qubein is a distinguished American and president of High Point University (HPU). In just one short decade and amidst the Great Recession, Qubein raised and invested two billion dollars to transform the university into U.S. News and World Report's #1 Best and #1 Most Innovative Regional College in the South. During his presidency, HPU has increased undergraduate enrollment from 1,450 to 5,000 – attracting students from all 50 states and 65 countries, expanding the campus from 90 to 430 acres, increasing scholarship opportunities from $8 million to $36 million annually and establishing five new academic schools. In addition to his faithful dedication to HPU, Qubein is a nationally-known business leader, strategic coach, serial entrepreneur and professional speaker. He is the author of a dozen books and is director of two New York Stock Exchange companies. He has also committed himself to raising millions of dollars in private investment to revitalize the city of High Point's downtown district.

Peter N. Foss completed a 36-year career, retiring as President of Olympic Sponsorship and Corporate Sales at GE and then returned to the GE Health care team. Foss is completing a mission he started to advance the understanding, treatment and prevention of concussions with the GE/NFL brain research effort.

About nThriveFrom Patient-to-PaymentSM, nThrive provides all the technology, advisory expertise, services, analytics and education programs health care organizations need to thrive in the communities they serve. Formerly known as MedAssets, Precyse and Equation, nThrive is built on a legacy of excellence. Most recently, nThrive acquired two leaders in their fields, Adreima – a provider of patient-centered, clinically integrated revenue cycle services that help patients find coverage and meet their financial obligations – and e4e Health care Services – a business process outsourcing company. The five organizations together combine top talent and capabilities in the health care industry into a single enterprise. www.nthrive.com

Media Contact:
Francesca Richards, nThrive
484-948-1553
frichards@nthrive.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nthrive-selects-board-of-directors-300481797.html

SOURCE nThrive

NEXT ARTICLE

More From BioPortfolio on "nThrive Selects Board of Directors"

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...